Citations for
1EGFR, LIMA1
Epidermal growth factor promotes protein degradation of epithelial protein lost in neoplasm (EPLIN), a putative metastasis suppressor, during epithelial-mesenchymal transition.
Zhang S, Wang X, Iqbal S, Wang Y, Osunkoya AO, Chen Z, Chen Z, Shin DM, Yuan H, Wang YA, Zhau HE, Chung LW, Ritenour C, Kucuk O, Wu D.
J Biol Chem 288(3):1469-79. doi: 10.1074/jbc.M112.438341. Epub 2012 Nov 27. 2013
2LIMA1
EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y, Sanders AJ, Zhang L, Jiang WG.
Anticancer Res 32(4):1283-9. 2012
3LIMA1
Epithelial protein lost in neoplasm (EPLIN) interacts with α-catenin and actin filaments in endothelial cells and stabilizes vascular capillary network in vitro.
Chervin-Pétinot A, Courçon M, Almagro S, Nicolas A, Grichine A, Grunwald D, Prandini MH, Huber P, Gulino-Debrac D.
J Biol Chem. 287(10):7556-72. 2012
4LIMA1
EPLIN-α expression in human oesophageal cancer and its impact on cellular aggressiveness and clinical outcome.
Liu Y, Sanders AJ, Zhang L, Jiang WG.
Anticancer Res. 32(4):1283-9. 2012
5CTNNA1, LIMA1
Mechanosensitive EPLIN-dependent remodeling of adherens junctions regulates epithelial reshaping.
Taguchi K, Ishiuchi T, Takeichi M.
J Cell Biol 194(4):643-56. Epub 2011 Aug 15. 2011
6LIMA1
EPLIN downregulation promotes epithelial-mesenchymal transition in prostate cancer cells and correlates with clinical lymph node metastasis.
Zhang S, Wang X, Osunkoya AO, Iqbal S, Wang Y, Chen Z, Müller S, Chen Z, Josson S, Coleman IM, Nelson PS, Wang YA, Wang R, Shin DM, Marshall FF, Kucuk O, Chung LW, Zhau HE, Wu D.
Oncogene 30(50):4941-52. doi: 10.1038/onc.2011.199. Epub 2011 May 30. 2011
7LIMA1
EPLIN is a negative regulator of prostate cancer growth and invasion.
Sanders AJ, Martin TA, Ye L, Mason MD, Jiang WG.
J Urol 186(1):295-301. Epub 2011 May 20. 2011
8LIMA1
Novel interactors and a role for supervillin in early cytokinesis
Smith TC, Fang Z, Luna EJ.
Cytoskeleton (Hoboken). 67(6):346-64. 2010
9LIMA1
The impact of EPLINα (Epithelial protein lost in neoplasm) on endothelial cells, angiogenesis and tumorigenesis.
Sanders AJ, Ye L, Mason MD, Jiang WG.
Angiogenesis 13(4):317-26. Epub 2010 Sep 17. 2010
10LIMA1
Epithelial Protein Lost in Neoplasm alpha (Eplin-alpha) is transcriptionally regulated by G-actin and MAL/MRTF coactivators.
Leitner L, Shaposhnikov D, Descot A, Hoffmann R, Posern G.
Mol Cancer 9:60. 2010
11LIMA1
EPLIN mediates linkage of the cadherin catenin complex to F-actin and stabilizes the circumferential actin belt.
Abe K, Takeichi M.
Proc Natl Acad Sci U S A 105(1):13-9. Epub 2007 Dec 18. 2008
12LIMA1
Characterization of porcine EPLIN gene revealed distinct expression patterns for the two isoforms.
Wang H, Wang H, Zhu Z, Yang S, Feng S, Li K.
Anim Biotechnol 18(2):101-8. 2007
13LIMA1
EPLIN regulates actin dynamics by cross-linking and stabilizing filaments.
Maul RS, Song Y, Amann KJ, Gerbin SC, Pollard TD, Chang DD.
J Cell Biol 160(3):399-407. 2003
14LIMA1
Characterization of mouse epithelial protein lost in neoplasm (EPLIN) and comparison of mammalian and zebrafish EPLIN.
Maul RS, Sachi Gerbin C, Chang DD.
Gene. 262(1-2):155-60. 2001
15LIMA1
Characterization of the human EPLIN (Epithelial Protein Lost in Neoplasm) gene reveals distinct promoters for the two EPLIN isoforms.
Chen S, Maul RS, Kim HR, Chang DD.
Gene 248(1-2):69-76. 2000
16LIMA1
EPLIN, epithelial protein lost in neoplasm.
Maul RS, Chang DD.
Oncogene 18(54):7838-41. 1999